Matthew Jay Budoff

May 7, 2024 | dicardiology.com | Cardiac Imaging |Matthew Jay Budoff

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), has revealed that areas of age-related damage in the brain relate to motor outcomes after a stroke—a phenomenon that may be under-recognized in stroke research. The study was published online on May 3, 2024, in Neurology, the medical journal of the American Academy of Neurology.

Apr 23, 2024 | dicardiology.com | Cardiac Imaging |Matthew Jay Budoff

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. This cutting-edge mobile solution is designed to revolutionize cardiac care by directly providing state-of-the-art cardiac PET/CT imaging services to medical facilities on their schedule.

Mar 19, 2024 | dicardiology.com | Cardiac Imaging |Matthew Jay Budoff

News | Cardiovascular Business | March 19, 2024 Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imagingMarch 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the “Amalgamation Agreement”) dated March 17, 2024 with Conavi Medical Inc. (“Conavi”) to combine the companies in an all-stock transaction.

Mar 5, 2024 | dicardiology.com | Cardiac Imaging |Matthew Jay Budoff

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision. Other benefits of cardiac PET include consistent, high-quality images, low radiation exposure and short acquisition protocols.

Feb 23, 2024 | dicardiology.com | Cardiac Imaging |Matthew Jay Budoff

News | Artificial Intelligence | February 23, 2024 FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery diseaseFebruary 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. Food and Drug Administration (FDA)-cleared Cleerly ISCHEMIA software device applied to a non-invasive coronary CT angiogram (CCTA) can be billed using the new .